Skip to main content
Free research Free research Free assay review with research home and workspace preview
Quick search ChEMBL 36
Assay Detail

CHEMBL5347352

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding
Inhibition of P13Kdelta (unknown origin)
13
Total Activities
13
Compounds Tested
1
Activity Types
0
Assay Parameters

Assay Information

Assay Type Binding
Organism Homo sapiens
Confidence 9 — Direct single protein target
Curated By Autocuration

Publication

Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents.
Occhiuzzi MA, Lico G, Ioele G, De Luca M, Garofalo A, Grande F.
Eur J Med Chem (2023) 246 : 114971 -114971
PubMed 36462440 · DOI

Activity Statistics

Type Count Avg pChEMBL Best pChEMBL
IC50 13 7.95 9.62

Compounds Tested

Compound Name Phase Activities Best pChEMBL
CHEMBL3039502 DUVELISIB 4.0 1 9.62
CHEMBL3544966 GSK-1059615 1.0 1 8.70
CHEMBL3813842 PAXALISIB 2.0 1 8.52
CHEMBL586702 ZSTK-474 2.0 1 8.30
CHEMBL3218576 COPANLISIB 4.0 1 8.19
CHEMBL1922094 APITOLISIB 2.0 1 8.15
CHEMBL3948730 UMBRALISIB 4.0 1 7.66
CHEMBL4297584 TENALISIB 2.0 1 7.61
CHEMBL5278435 1 7.50
CHEMBL4297181 SAMOTOLISIB 2.0 1 7.42
CHEMBL3393066 VS-5584 1.0 1 7.38
CHEMBL3545366 VOXTALISIB 2.0 1 7.37
CHEMBL2017974 BUPARLISIB 3.0 1 6.94

Activity Data

Compound Name Type Rel. Value Units pChEMBL
CHEMBL3039502 DUVELISIB IC50 = 0.24 nM 9.62
CHEMBL3544966 GSK-1059615 IC50 = 2.0 nM 8.70
CHEMBL3813842 PAXALISIB IC50 = 3.0 nM 8.52
CHEMBL586702 ZSTK-474 IC50 = 5.0 nM 8.30
CHEMBL3218576 COPANLISIB IC50 = 6.4 nM 8.19
CHEMBL1922094 APITOLISIB IC50 = 7.0 nM 8.15
CHEMBL3948730 UMBRALISIB IC50 = 22.0 nM 7.66
CHEMBL4297584 TENALISIB IC50 = 24.5 nM 7.61
CHEMBL5278435 IC50 = 32.0 nM 7.50
CHEMBL4297181 SAMOTOLISIB IC50 = 38.0 nM 7.42
CHEMBL3393066 VS-5584 IC50 = 42.0 nM 7.38
CHEMBL3545366 VOXTALISIB IC50 = 43.0 nM 7.37
CHEMBL2017974 BUPARLISIB IC50 = 116.0 nM 6.94